Literature DB >> 10790138

Quantitation of cell-free and cell-associated Kaposi's sarcoma-associated herpesvirus DNA by real-time PCR.

I E White1, T B Campbell.   

Abstract

A real-time PCR assay for quantitation of Kaposi's sarcoma-associated herpes virus (KSHV or human herpesvirus 8) DNA was evaluated. The linear dynamic range was 10 to 10(5) copies of KSHV DNA (r(2) > 0.99). The accuracy of DNA purification and quantitation was less than +/-0.4 log(10) copies for samples that contained from 10 to 10(5) copies of KSHV DNA. Cell-associated KSHV DNA was quantitated over a range of infected cell frequencies from 0. 1 to 10(-5), and cell-free KSHV DNA in plasma was quantitated over a range of 100 to 10(6) copies/ml. Real-time PCR provides a convenient method for quantitation of cell-free and cell-associated KSHV DNA in laboratory and clinical specimens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790138      PMCID: PMC86648     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Real time quantitative PCR.

Authors:  C A Heid; J Stevens; K J Livak; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

2.  Human herpesvirus 8 group B and C variants circulating in São Paulo, Brazil.

Authors:  A Caterino-de-Araujo
Journal:  J Infect Dis       Date:  1998-04       Impact factor: 5.226

3.  Strain variability among Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genomes: evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate.

Authors:  J C Zong; C Metroka; M S Reitz; J Nicholas; G S Hayward
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

5.  Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end.

Authors:  L J Poole; J C Zong; D M Ciufo; D J Alcendor; J S Cannon; R Ambinder; J M Orenstein; M S Reitz; G S Hayward
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma.

Authors:  C Lebbé; F Agbalika; P de Crémoux; M Deplanche; M Rybojad; E Masgrau; P Morel; F Calvo
Journal:  Arch Dermatol       Date:  1997-01

7.  Development of a quantitative competitive polymerase chain reaction for human herpesvirus 8.

Authors:  M J Lock; P D Griffiths; V C Emery
Journal:  J Virol Methods       Date:  1997-02       Impact factor: 2.014

8.  Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma.

Authors:  P S Moore; L A Kingsley; S D Holmberg; T Spira; P Gupta; D R Hoover; J P Parry; L J Conley; H W Jaffe; Y Chang
Journal:  AIDS       Date:  1996-02       Impact factor: 4.177

9.  Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae.

Authors:  P S Moore; S J Gao; G Dominguez; E Cesarman; O Lungu; D M Knowles; R Garber; P E Pellett; D J McGeoch; Y Chang
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Human herpesvirus 8 in Italian HIV-seronegative patients with Kaposi sarcoma.

Authors:  P Cattani; M Capuano; I Lesnoni La Parola; R Guido; R Santangelo; F Cerimele; C Masini; G Nanni; G Fadda; D Cerimele
Journal:  Arch Dermatol       Date:  1998-06
View more
  14 in total

Review 1.  Real-time PCR in virology.

Authors:  Ian M Mackay; Katherine E Arden; Andreas Nitsche
Journal:  Nucleic Acids Res       Date:  2002-03-15       Impact factor: 16.971

2.  Human herpesvirus 8 load in matched serum and plasma samples of patients with AIDS-associated Kaposi's sarcoma.

Authors:  Abeltje M Polstra; Remco Van Den Burg; Jaap Goudsmit; Marion Cornelissen
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

3.  Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe.

Authors:  Kristine M Erlandson; Ivy Gudza; Suzanne Fiorillo; Buxton Ndemera; Robert T Schooley; Lovemore Gwanzura; Margaret Borok; Thomas B Campbell
Journal:  Int J Infect Dis       Date:  2014-04-21       Impact factor: 3.623

4.  High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.

Authors:  Craig S Miller; Joseph R Berger; Yunanan Mootoor; Sergei A Avdiushko; Hua Zhu; Richard J Kryscio
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

5.  Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids.

Authors:  Francesco Broccolo; Giuseppe Locatelli; Loredana Sarmati; Sara Piergiovanni; Fabrizio Veglia; Massimo Andreoni; Stefano Buttò; Barbara Ensoli; Paolo Lusso; Mauro S Malnati
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

6.  Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes.

Authors:  Florian Bihl; Murli Narayan; John V Chisholm; Leah M Henry; Todd J Suscovich; Elizabeth E Brown; Tania M Welzel; Daniel E Kaufmann; Tauheed M Zaman; Sheila Dollard; Jeff N Martin; Fred Wang; David T Scadden; Kenneth M Kaye; Christian Brander
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

7.  Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment.

Authors:  Craig S Miller; Sergei A Avdiushko; Richard J Kryscio; Robert J Danaher; Robert J Jacob
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

8.  Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acid.

Authors:  Laurie T Krug; Veronika P Pozharskaya; Yimin Yu; Naoki Inoue; Margaret K Offermann
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  A 6-aminoquinolone compound, WC5, with potent and selective anti-human cytomegalovirus activity.

Authors:  Beatrice Mercorelli; Giulia Muratore; Elisa Sinigalia; Oriana Tabarrini; Maria Angela Biasolo; Violetta Cecchetti; Giorgio Palù; Arianna Loregian
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

Review 10.  Laboratory diagnosis of human herpesvirus 8 infection in humans.

Authors:  R Tedeschi; J Dillner; P De Paoli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.